The global DNA Synthesizer Market is estimated to be valued at US$ 4.3 Bn in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview
DNA synthesizers are used for artificial synthesis of DNA strands or oligonucleotides and rely on DNA synthesis technology for the purpose. DNA synthesizers automate the chemical assembly of nucleic acid polymers with desired nucleotide sequences for applications in genomics and healthcare.
Market key trends
Emergence of high throughput DNA synthesis technologies that can quickly synthesize multiple DNA strands in short time has been a key trend. Technologies like oligonucleotide array-based synthesis allow parallelized production of thousands to millions of oligonucleotides on a single microchip or microarray. This has accelerated genomics research applications involving DNA sequencing and molecular diagnostics. Automated liquid handling systems that work with array-based synthesizers have further contributed to productivity gains in DNA synthesis.
Read More @ https://www.coherentmarketinsights.com/market-insight/dna-synthesizer-market-5913
SWOT Analysis
Strength: DNA synthesizers provide accurate DNA fragment assembly in an automated manner, reducing manual errors. They offer high throughput DNA synthesis at affordable costs.
Weakness: DNA synthesizers are expensive to purchase and maintain. Troubleshooting errors can be challenging for inexperienced users.
Opportunity: Growing fields such as synthetic biology, gene & cell therapy driving demand. Rise in genomics research and advancements in DNA data storage open new opportunities.
Threats: Strict regulations around genetic engineering may hamper market growth. Alternatives such as gene editing threaten replacement of DNA synthesis.
Key Takeaways
The global DNA Synthesizer Market is expected to witness high growth at a CAGR of 20% over the forecast period due to growing applications in genomics research and synthetic biology. Advancements in DNA data storage also contributes to market growth.
Regional analysis: North America dominates the global market due to presence of leading players and high adoption of genomic technologies. Asia Pacific exhibits fastest growth owing to increasing R&D investments and expanding biotechnology sector in China and India.
Key players operating in the DNA Synthesizer market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation, GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience. These players are focusing on new product launches and partnerships to strengthen their market position.
